Current NDC auxiliary source row compounder:884

This page is keyed by dataset, FDA.report source record ID, and physical source row number. Empty values are shown rather than omitted.

Complete normalized row#

Record Source: ndc_compounder_zip
Product Ndc Raw: 73198-020
Product Ndc: 73198-020
Product Ndc Digits: 73198020
Product Type Name: HUMAN COMPOUNDED DRUG
Proprietary Name: QM-4
Proprietary Name Suffix: [empty]
Nonproprietary Name: Papaverine Hydrochloride 30 mg/mL Phentolamine Mesylate 3 mg/mL Alprostadil 300 mcg/mL Atropine Sulfate 0.2 mg/mL
Dosage Form Name: INJECTION, SOLUTION
Route Name: INTRACAVERNOUS
Marketing Category Name: OUTSOURCING FACILITY COMPOUNDED HUMAN DRUG PRODUCT (EXEMPT FROM APPROVAL REQUIREMENTS)
Labeler Name: Olympia Pharmacy
Establishment Name: Olympia Pharmacy
Establishment Fei: [empty]
Substance Name: PAPAVERINE HYDROCHLORIDE; PHENTOLAMINE MESYLATE; ALPROSTADIL; ATROPINE SULFATE
Active Ingredients Info: 30 mg/1 mL; 3 mg/1 mL; 300 ug/1 mL; .2 mg/1 mL
History Active Ingredients Raw: PAPAVERINE HYDROCHLORIDE; PHENTOLAMINE MESYLATE; ALPROSTADIL; ATROPINE SULFATE
History Active Ingredients Info Raw: 30 mg/1 mL; 3 mg/1 mL; 300 ug/1 mL; .2 mg/1 mL
History Dosage Raw: INJECTION, SOLUTION
Dea Schedule: [empty]
Package Ndc Raw: 73198-020-03
Package Ndc: 73198-020-03
Package Ndc Digits: 7319802003
Package Ndc11: 73198002003
Package Description: 2.5 mL in 1 VIAL, MULTI-DOSE (73198-020-03)
Reporting Period Raw: 2026-1
Reporting Period: 2026-1
Normalization Status: valid
Source Url: https://www.accessdata.fda.gov/cder/compounders_ndc_directory.zip
Source Archive: compounders_ndc_directory.zip
Source File: compounders_ndc_directory.txt
Source Date: 2026-09-18
Source Last Modified: Fri, 18 Sep 2026 15:17:23 GMT
Source Archive Sha256: 222f6800f79cb1a0fa79431b7226bd6b34899999dbf086af51004a96774ada98
Source Member Sha256: f8d9743e5616579a34d614887e86a53913efa0a63d3138d59d2f87cbb4d0cc17
Source Record Id: compounder:884
Source Row Number: 884
Source Row Hash: ff9c74dc3ee0c168fba7a27669306c87e935be22636ae6d509282dee713418ec
Import Run Id: 20261021T042902Z
Loaded At: 2026-10-21 04:33:26

Exact raw FDA source fields#

{
    "ROUTENAME": "INTRACAVERNOUS",
    "PRODUCTNDC": "73198-020",
    "DEASCHEDULE": "",
    "LABELERNAME": "Olympia Pharmacy",
    "SUBSTANCENAME": "PAPAVERINE HYDROCHLORIDE; PHENTOLAMINE MESYLATE; ALPROSTADIL; ATROPINE SULFATE",
    "DOSAGEFORMNAME": "INJECTION, SOLUTION",
    "NDCPACKAGECODE": "73198-020-03",
    "PRODUCTTYPENAME": "HUMAN COMPOUNDED DRUG",
    "PROPRIETARYNAME": "QM-4",
    "REPORTINGPERIOD": "2026-1",
    "NONPROPRIETARYNAME": "Papaverine Hydrochloride 30 mg/mL Phentolamine Mesylate 3 mg/mL Alprostadil 300 mcg/mL Atropine Sulfate 0.2 mg/mL",
    "PACKAGEDESCRIPTION": "2.5 mL in 1 VIAL, MULTI-DOSE (73198-020-03) ",
    "ACTIVEINGREDIENTSINFO": "30 mg/1 mL; 3 mg/1 mL; 300 ug/1 mL; .2 mg/1 mL",
    "MARKETINGCATEGORYNAME": "OUTSOURCING FACILITY COMPOUNDED HUMAN DRUG PRODUCT (EXEMPT FROM APPROVAL REQUIREMENTS)",
    "PROPRIETARYNAMESUFFIX": ""
}

Normalization notes#

[]

Current status projection#

Dataset: compounder
Record Source: ndc_compounder_zip
Source Record Id: compounder:884
Source Row Number: 884
Status Scope: package
Lookup Ndc: 73198-020-03
Lookup Ndc Digits: 7319802003
Product Ndc: 73198-020
Product Ndc Digits: 73198020
Package Ndc: 73198-020-03
Package Ndc Digits: 7319802003
Package Ndc11: 73198002003
Product Id: [empty]
Status Code: COMPOUNDER
Status Label: Outsourcing facility compounded drug report
Reporting Period Raw: 2026-1
Reporting Period: 2026-1
Source Table: fda_ndc_aux_compounder
Source File: compounders_ndc_directory.txt
Source Date: 2026-09-18
Source Row Hash: ff9c74dc3ee0c168fba7a27669306c87e935be22636ae6d509282dee713418ec
Import Run Id: 20261021T042902Z
Loaded At: 2026-10-21 04:33:26